Cancer Stem Cells

A recent review article provides a snapshot of the current advances relating to the role of the N6‐methyladenosine RNA modification in cancer stem cells

Researchers discover the resistance of CD44+ prostate cancer stem cells to combined docetaxel/fenofibrate treatment

The existence of a high-plasticity cell state supports high tumorigenic capacity and drug resistance of lung adenocarcinoma cells and associates with poor patient prognosis

A new perspective discusses the effects of genetically and chemically dysregulating mitochondrial proteases in AML

A curative immunotherapy for AML remains undescribed, possibly due to the resistance of the LSCs

Microgravity provides a unique environment for cell culture and can induce cellular changes and processes unachievable under normal gravitational conditions.

Despite strong correlations with poor prognosis, it remains unclear whether necrosis represents a cause or a consequence of malignant glioma progression.  Now, a new study from the labs of

The premise and predictions of the cancer stem cell (CSC) model of cancer are being evaluated in the clinic as cancer stem cell‐targeted therapies enter clinical trials.

A new STEM CELLS

The tripartite‐motif (TRIM) family of proteins participate in a variety of cellular functions and biological processes, and recent data has revealed their significant role in the acquisition and maintenance of the stem cell phenotype.